Perineal versus intravaginal electrical stimulation for idiopathic overactive bladder in women
Official title: Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder
Run by Pamukkale University · NCT07366918 · Data updated 2026-11-12
This study will test whether adding intravaginal or perineal electrical stimulation to bladder training helps women with idiopathic overactive bladder reduce urgency and leakage compared with bladder training alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 63 (estimated) |
| Sponsor | Pamukkale University Academic / other |
| Locations | 1 site (Denizli) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | January 1, 2027 |
| Registry record updated | July 29, 2026 |
| Trial ID | NCT07366918 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with idiopathic overactive bladder who are intolerant of or unresponsive to antimuscarinic or mirabegron therapy (off these drugs for at least 4 weeks) and who have pelvic floor muscle strength of at least 3/5 are ideal candidates.
✕Probably not a fit
Patients with pure stress urinary incontinence, recent conservative therapy for OAB, pregnancy, active vaginal or urinary infection, cancer, recent urogynecologic surgery, genital conditions preventing use of vaginal probes or perineal electrodes, or very weak pelvic floor muscles are unlikely to benefit or are ineligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, double-blind, placebo-controlled comparison enrolling 63 women with idiopathic overactive bladder who are intolerant of or unresponsive to oral OAB medications. Participants are randomized into three groups (intravaginal electrical stimulation plus bladder training, perineal electrical stimulation plus bladder training, or bladder training alone) and treated over an 8-week period. Clinical measures related to incontinence and quality of life are recorded before and after the treatment period. The study aims to determine whether one stimulation approach provides superior symptom relief and life-quality benefit compared with bladder training alone.
Why it matters
Potential benefit: If successful, the approach could offer a non-drug option that reduces urgency and leakage and improves quality of life for women with idiopathic OAB.
How similar studies have gone: Previous randomized trials and meta-analyses of pelvic electrical stimulation (including intravaginal and perineal approaches) have shown symptom improvement for some women with OAB, though results are mixed and effect sizes vary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women over the age of 18 with a clinical diagnosis of idiopathic OAB * Intolerant or unresponsive to antimuscarinic or oral β3 adrenoceptor agonist (mirabegron) medications and not using them for at least 4 weeks * Ability to understand the procedures, advantages, and potential side effects * Ability to provide written, informed consent * Pelvic floor muscle (PFM) strength of 3/5 or higher (modified Oxford scale, minimum: 0 - maximum: 5) Exclusion Criteria: * Women with pure stress urinary incontinence * History of conservative treatment for OAB within the last 6 months (MI, IVES, perineal ES, etc.) * Pregnant or planning to become pregnant at the time of the study * Diagnosis of vaginal infection, urinary tract infection, or cancer * Women with urinary incontinence within the last 3 months Those who have undergone urogynecological surgery * Those with genital area disorders that may preclude the use of a vaginal probe or perineal electrode * Those diagnosed with stage 2 or higher according to the Pelvic Organ Prolapse Assessment (POP-Q) * Those with a pacemaker or implanted defibrillator * Those with neurogenic bladder or a history of neurological disease * Those with a urine residual of more than 100 ml detected by ultrasound (using an ultrasound device) * Those with allergies to condoms or lubricating gels used with a vaginal probe or perineometer
Where it's running
-
Pamukkale University
Denizli, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Rabia Melis Gundogan M.D.
- Email: r.melisgun@gmail.com
- Phone: +902584444747
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Educational video before urodynamic testing to see if it lowers anxiety
This study tests whether watching a short educational video before urodynamics helps reduce anxiety for women undergoing the test.
-
Extended ambulatory bladder monitoring with the Glean Urodynamics System
This will test whether the Glean Urodynamics System can safely monitor bladder function in adults who need urodynamic testing, both during a clinic visit and for up to 24 hours at home.
-
Assessing tissue elasticity in women with urinary incontinence
This study is testing a new way to see if the stiffness of tissue around the urethra can help doctors better diagnose stress urinary incontinence in women.
-
Comparing solifenacin or mirabegron with local estrogen to combined pharmacotherapy for overactive bladder
This study is testing whether combining solifenacin or mirabegron with local estrogen works better than just using solifenacin and mirabegron alone for women with overactive bladder who haven't found relief from other treatments.
-
Using high-dose vitamin D to treat overactive bladder in children
This study is testing if giving high-dose vitamin D along with regular therapy can help children with wet overactive bladder feel better compared to just therapy or therapy with a medication.
-
Comparing two treatments for women with overactive bladder
This study tests whether a combination of two medications or a medication with vaginal estrogen cream helps women with overactive bladder feel better and have fewer symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.